Bico's Biosero Secures Major Contract Worth 143.6 Million SEK
Bico's subsidiary Biosero has secured a 143.6 million SEK contract with a global pharmaceutical firm.
- • Biosero signed a framework agreement in August 2025.
- • First purchase orders total 15.2 million dollars.
- • Contract highlights Bico's growth in laboratory automation.
- • Announcement made via press release.
Key details
Biosero, a subsidiary of Bico, has landed a significant framework agreement with a prominent global pharmaceutical company. Announced on September 5, 2025, the deal showcases Biosero's growing footprint in integrated laboratory automation solutions. Initially, this agreement has led to purchase orders aggregating approximately 15.2 million dollars, which is around 143.6 million Swedish kronor. This development signals Bico's capability to attract lucrative contracts within the competitive pharmaceutical industry, reinforcing the importance of its operations in the biotechnology sector.
This article was translated and synthesized from Swedish sources, providing English-speaking readers with local perspectives.
Source articles (1)
Latest news
Calls for Worker Experience and Licensing Reform in Swedish Politics and Construction Industry
Lynk & Co launches advanced electric sedan; Audi Quattro resurrected with modern muscle
Sweden Launches Major Digital Transformation Support for 500,000 SMEs by 2030
New Weight Loss Drug Semaglutide Linked to Improved Mental Health in Sweden
Felicia Schröder’s Hat-Trick and Expert Predictions Highlight Swedish Cup Semi-Finals
Sweden Faces Sharp Fuel Price Hikes Amid Middle East Conflict, Pressuring Economy and Consumers
The top news stories in Sweden
Delivered straight to your inbox each morning.